- AddressMonash University
Associate Professor Bing Wang received his PhD from La Trobe University in 1996.
Dr Bing Wang is an Associate Professor in the Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University. He has a major interest in cytokine signalling in cardiovascular diseases with the aim to identify novel therapeutic targets for drug development and his areas of expertise are molecular and cellular biology, chemistry and biochemistry. After completing his PhD in Biochemistry in 1996 at La Trobe University, Dr Wang worked as senior research officer at the Baker Heart Research Institute for four years where he continued with his work in the area of cellular signalling in cardiovascular diseases particularly in examining adrenergic receptor signalling in cardiac hypertrophy. Dr Wang also worked at Cytopia Research Pty Ltd as a Senior Scientist and Head of Molecular Biology Department. During several years at Cytopia, he established a cardiovascular drug discovery and development program, resulting in several patents. In 2005, Dr Wang took up position with Prof Krum at CCRE in Therapeutic as a senior research fellow at Monash University, where he is focusing on academic research aiming to discover new targets/therapeutics for the treatment of cardiovascular and related diseases. His current research areas include pharmacology of cardiovascular diseases (CVDs), novel therapeutics for CVDs, drug discovery and development, biomarker discovery and development.
A/Prof Wang is the Head of Biomarker Discovery Laboratory within School of Public Health and Preventive Medicine, Monash University, and responsible for the development biomarkers analytical assays and discovery program. The Biomarker Discovery Laboratory provides not only the facility and expertise to analyse known biomarkers, but also the opportunity to discover and develop novel biomarkers that are of clinical utility in the diagnosis, prognosis and monitoring of disease conditions. The Biomarker Discovery Laboratory further affords the opportunity to study mechanisms of disease progression and therapeutic responses. In addition, he also supervises staff and students in the area of his expertise with excellent outcomes.
He published more than 50 papers in major international journals including Circulation; J. Biol. Chem.; Am J. Physiol. Heart and Circ.; Circ Res. European Heart Journal and several review articles and book chapters. He received funding from NHMRC, National Heart Fund (NHF) and Monash University for a number of research projects and new drugs development.
A/Prof Bing Wang is member of the International Society of Heart Research.